Chindex International Announces Shelf Registration, Related Strategy an...(rtunities presentthemselves as prospecti...)

Date:5/13/2008

rtunities present themselves as prospective drivers of further growth in our industry. We need to be properly positioned and prepared to respond nimbly to these strategic opportunities, such as potential acquisitions and venture projects. Accordingly, as we have noted, the shelf registration statement is intended to give us greater flexibility to take advantage of favorable market conditions and to quickly respond to these strategic opportunities.

"Separately, today we announced that our earnings call for last fiscal year, ended March 31, 2008, will be held on June 12, at which time we will report strong overall results for that year. Looking forward in the current fiscal year 2009, we currently believe that our hospital division will achieve an approximately 30% increase over last fiscal year's revenues, with continuing improvement of operating income as a percentage of revenue. Our medical products division had a disappointing 2008 fiscal year and final quarter primarily due to persisting delays in product registrations, which are subject to Chinese Governmental bureaucratic approval practices, and some of which have been in process for well over a year. Subject to the receipt of these approvals and the execution of an increased number of U.S. and German Government-backed loan projects, we expect the medical products division to return to profitability in the current year."

The shelf registration statement has not yet become effective. The securities offered by the Company under the shelf registration statement may not be sold, nor may offers to buy the securities be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Any
'/>"/>

SOURCE Chindex International, Inc. Copyright©2008 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
2. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
3. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
4. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
5. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
8. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
9. Arrow International Files and Mails Definitive Proxy Materials
10. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
11. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)